| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.149 | 61 | 2.419 | 2.011 | 2.642 | 2.274 | 3.352 |
| Total Income - EUR | - | - | - | 2.149 | 61 | 2.419 | 2.011 | 2.642 | 2.274 | 3.352 |
| Total Expenses - EUR | - | - | - | 34 | 971 | 87 | 153 | 466 | 1.081 | 1.002 |
| Gross Profit/Loss - EUR | - | - | - | 2.115 | -910 | 2.332 | 1.858 | 2.176 | 1.193 | 2.350 |
| Net Profit/Loss - EUR | - | - | - | 2.051 | -912 | 2.260 | 1.805 | 2.098 | 1.006 | 2.020 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Octavic Medtech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 1.012 | 657 | 298 | 0 |
| Current Assets | - | - | - | 2.094 | 1.143 | 3.425 | 4.119 | 1.965 | 1.078 | 3.333 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 306 | 0 | 0 | 0 | 17 |
| Cash | - | - | - | 2.094 | 1.143 | 3.119 | 4.119 | 1.965 | 1.078 | 3.316 |
| Shareholders Funds | - | - | - | 2.044 | 1.092 | 3.331 | 5.062 | 2.310 | 1.112 | 3.125 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 50 | 51 | 93 | 68 | 312 | 264 | 208 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Octavic Medtech Srl